NEWS
Home  >  News
Logistical problems snag COVID-19 vaccine distribution: Galvez
ABS-CBN News
Posted at Oct 20 2021 08:10 AM | Updated as of Oct 20 2021 12:41 PM
Children pose for photos after getting inoculated with the COVID-19 vaccine at the Pasig City General Hospital in Pasig City on Oct. 15, 2021. Jonathan Cellona, ABS-CBN News
MANILA — While the Philippines has secured an adequate amount of COVID-19 shots, logistical problems are delaying their distribution to various regions, an official leading the vaccination drive said.
"Noong dati po, supply po ang problema po natin. Ngayon po ang problema po natin 'yung throughput, kung paano po natin ia-administer 'yung mga vaccine," Secretary Carlito Galvez Jr. told President Rodrigo Duterte in a taped meeting that aired in the wee hours of Wednesday. 
(Previously, the supply was our problem. Now, our problem is the throughput, how we will administer the vaccines.) 
After experiencing a shortage of vaccines in March and September, the Philippines has now secured a stockpile of about 39 million jabs, said Galvez, chief implementer of the National Task Force Against COVID-19.
But he noted that the deployment of these vaccine doses to various inoculation sites take about 7 to 9 days. 
"Ina-address na po natin 'yong (we are addressing the) logistical challenge at the regional, provincial, and municipal deployment and administration," said Galvez, who also serves as vaccine "czar." 
The Philippines has tallied some 2.7 million overall coronavirus infections, among the highest in Asia. The country has so far fully vaccinated at least 24 million of its 109 million population. 
The government wants to vaccinate at least 50 million people by Christmas.
‘For a happy Christmas’: PH raises daily vaccination target to 1.5 million jabs
Duterte thanks Japan, US for COVID vaccine donations
Watch more on iWantTFC
Read More:  COVID   COVID-19   coronavirus   COVID19  COVID Philippines   COVID updates   COVID latest Philippines   COVID vaccine  
© 2021 ABS-CBN Corporation. All Rights Reserved.
ABOUT
CAREERS
PRIVACY
TERMS
CONTACT US
ADVERTISE WITH US